During hemoglobin proteolysis, inside the malarial parasite digestive vacuole, free heme is 1 released. Owing to its capacity to create oxidative damage to cell membranes and parasite 2 proteins, redox-active free heme (ferriprotoporphyrinIX: PPIXFe) is toxic. To avoid this toxicity, 3
Plasmodium converts free heme entities in an inert microcrystal made by aggregation of heme-4 dimers called hemozoin or malaria pigment (5) . Because the hemozoin pathway is unique to the 5 malaria parasite, it offers an attractive target for the design of new antimalarials. Chloroquine, a 6 blood schizonticide, is considered as an efficient inhibitor of the hemozoin formation (21) . 7
Chloroquine stacks with heme to form a stable π-π complex PPIXFe-chloroquine which is not 8 incorporated into hemozoin and that could kill the parasite via a redox process. In vitro, β-9 hematin, a crystal structurally and chemically identical to hemozoin (14) could be synthesized 10 from hemin (PPIXFe-Cl) under acidic conditions with or without parasitic material (4, 6, 8, 19, 11 21) . Thus, drugs acting as inhibitors of hemozoin formation, such as chloroquine, can be 12 evaluated in vitro by monitoring their ability to prevent the formation of β-hematin from hemin. 13
Potential antimalarial trioxaquines  , in vitro and in vivo effective against both chloroquine-14 sensitive and chloroquine-resistant strains of Plasmodium, have been prepared in our laboratory 15 by covalent attachment of a trioxane entity to N-(7-chloro-4-quinolinyl)-1,2-ethanediamine 16 (DU1301) or primaquine (DU2303) (Figure 1) (1, 2) . Recently, we showed that the trioxane 17 motif of these hybrid molecules was responsible for the artemisinin-like activity since an adduct 18 heme-trioxaquine has been characterized, similar to that obtained with artemisinin derivatives 19 (11, 16, 17) . To further document the mode of action of these new antimalarial compounds, we 20 wanted to assess if these hybrid trioxaquines might have a dual activity (heme-alkylation and 21 hemozoin inhibitor) by evaluating their capacity to inhibit β-hematin formation in vitro, using 22 chloroquine as comparator. Different methods have been proposed to study the inhibition of β-hematin formation by drugs 24 (3, 12) . One of these methods is particularly adapted to evaluate compounds with low water 25 solubility like trioxaquines (15) . 312 µL of a 16 mM solution of hemin dissolved in DMSO were 26 added to a suitable molar equivalent of the tested compound dissolved in 312 µL of DMSO. In a 27 control test, hemin was added to 312 µL of DMSO. 624 µL of H 2 O (milli-Q quality) were added 28 before the initiation of β-hematin formation with 1.25 mL of 10 M acetate buffer (pH 5). The 29 final ratio of DMSO was kept constant at 25% (v/v). The solution was stirred at 37 °C for 18 h, 30 cooled on ice for 5 min and then filtered on centrifugal filter units ultrafree CL (4000 g, 10 min). 31
The pellets were washed eight times with 2 mL of warm H 2 O mQ (30 °C) in order to remove 32 acetate salts (4000 g, 10 min). The solid was dried under vacuum at 90 °C for 2 h. Infrared 33 spectra were obtained from disc of the solids (1.5 mg) in KBr pellets (200 mg). β-Hematin has 34 two characteristic sharp bands at 1660 cm -1 and 1210 cm -1 that are attributed to the carboxylate 35 groups coordinated to the iron atom of ferriprotoporphyrin (5). These two bands were missing in 36 the IR spectra when the inhibition occured. The major advantage of this infrared assay method 37 for β-hematin inhibition is that it allows unequivocal identification of the reaction products. A 38 disavantage is that it doesn't allow the quantification of the inhibition process. However, we 39 prefer this method to solubilization-based methods, because of its ability to provide a clear 40 answer concerning the formation of carboxylato-iron bonds that are essential in the dimerization 41 process that is at the origin of the hemozoin formation. The inhibiting capacity of trioxaquines, 42 DU1301 and DU2303, was compared to their own precursors (N-(7-chloro-4-quinolinyl)-1,2-43 ethanediamine, primaquine (HCl salt) and their trioxane-precursor, namely the trioxane entity 44 with a keto group replacing the aminoquinoline moiety of these hybrid molecules) and to 45 We found that 10 equivalents of chloroquine or N-(7-chloro-4-quinolinyl)-1,2-ethanediamine 48 were necessary to completely inhibit the formation of β-hematin as previously reported (7). It is 49 reasonable to assume that the 4-aminoquinoline entity of trioxaquines inhibits the formation of β-50 hematin via a non-covalent interaction with heme (12) . In contrast, the addition of a large excess 51 of primaquine dihydrochloride (up to 15 equivalents) did not inhibit the formation of β-hematin. 52
A C C E P T E D
Except few examples (20) , it is known that 8-aminoquinoline forms a weak complex with heme 53 that can not interfere with β-hematin formation (15) . Moreover, primaquine is an antimalarial 54 drug active against the liver stage but not the blood stage of Plasmodium. The four trioxane-55 containing molecules tested (artemisinin, artesunate, artemether and trioxane-precursor) did not 56 interfere with β-hematin synthesis up to 15 equivalents. These results are not surprising (9) , given 57 that these trioxane compounds have a mechanism of action that is distinct from that of simple 58 aminoquinolines (13) . Moreover, we found that addition of 3 equivalents of DU2303 resulted in 59 complete inhibition of β-hematin formation whereas addition of up to 15 equivalents of its 60 precursors, trioxane-precursor or primaquine, had no such effect. In parallel, only 2 equivalents 61 of DU1301 prevented the formation of β-hematin. Both trioxaquines are more potent inhibitors at 62 low charge than their quinoline precursors. The data from this IR study on heme crystallization 63 and the precedent results on heme-alkylation (11, 16, 17) suggest that these trioxaquines (hybrid 64 molecules) could have a dual mode of action: one chloroquine-like mechanism whereby 65 hemozoin formation is prevented and one artemisinin-like mechanism whereby of heme is 66 alkylated. 67
on October 16, 2017 by guest http://aac.asm.org/
Downloaded from
Artemisinin alkylates heme both in vitro and in vivo and forms a well-defined heme-68 artemisinin adduct mixture (Figure 2 and Figure 3A) (16, 17) . The infrared spectrum of a 69 equimolar mixture of heme and artemisinin was shown for comparison ( Figure 3B ). These 70 adducts should not be able to crystallize into hemozoin and could induce oxidative damages to 71 parasite biomolecules as it's reported for free heme (21) . We first checked if these heme-72 artemisinin adducts alone were able to dimerize under the conditions that were used for the 73 formation of β-hematin in control test. We found that the IR spectrum of these adducts treated 74 alone under heme crystallization conditions with acetate buffer for 18 h at 37 °C did not exhibit 75 bands at 1660 cm -1 and 1210 cm -1 as shown in Figure 3B . Moreover, the powder recovered was 76 soluble in DMSO and methanol, solvents that do not solubilize β-hematin (15) . We propose that 77 the bulky artemisinin residue linked to the porphyrin ring prevented the coordination of the 78 propionate side chain on the iron atom (preventing thus the initial dimerization, a required step in 79 the hemozoin formation). It should be noted that this result does not support the theoretical 80 studies suggesting that the dimerization of heme-artemisinin adducts is possible (18) . 81
We then checked the hypothesis of heme-artemisinin adducts acting as inhibitors of β-hematin 82 formation (18) . The inhibition was evaluated with adducts/hemin ratios ranging from 1 to 6 under 83 the conditions described above. The powder recovered after aqueous washing was washed again 84 with 5 mL of methanol in order to remove the excess of adducts. IR spectra were recorded after 85 drying the resulting powder under vacuum. We found that 5 equivalents of heme-artemisinin 86 adducts completely blocked the conversion of hemin to β-hematin. A recent study (10) suggested 87 that heme-artemisinin adducts were also able to inhibit the formation of β-hematin in the 88 presence of PfHRP-II (a histidine-rich protein involved in hemozoin formation). 89 
A C C E P T E D

